Key result
Medicare HRRP linked to minimal 0.02-percentage-point monthly increase in observation stays for target conditions.
Why the study?
The study was conducted to evaluate whether Medicare's Hospital Readmissions Reduction Program (HRRP) is associated with increased observation stay use.
Does Medicare's Hospital Readmissions Reduction Program (HRRP) increase the use of observation stays as a proportion of total hospitalizations for target conditions compared with nontarget conditions among fee-for-service Medicare beneficiaries?
Cohort (n=7,162,189)
Yes
Does Medicare's Hospital Readmissions Reduction Program (HRRP) increase the use of observation stays as a proportion of total hospitalizations for target conditions compared with nontarget conditions among fee-for-service Medicare beneficiaries?
Medicare's Hospital Readmissions Reduction Program was not meaningfully associated with differential increases in observation stay use for target conditions (such as heart failure and acute myocardial infarction) compared with nontarget conditions, indicating that rising observation stays are primarily driven by other factors like payment audits and clinical advances.
Answers are grounded in this paper and cite their sources.
HRRP shows minimal association with differential observation stay increases; leaves open other factors as primary drivers in Medicare trends.
OBJECTIVE: To evaluate whether Medicare's Hospital Readmissions Reduction Program (HRRP) is associated with increased observation stay use. DATA SOURCES AND STUDY SETTING: A nationally representative sample of fee-for-service Medicare claims, January 2009-September 2016. STUDY DESIGN: Using a difference-in-difference (DID) design, we modeled changes in observation stays as a proportion of total hospitalizations, separately comparing the initial (acute myocardial infarction, pneumonia, heart failure) and subsequent (chronic obstructive pulmonary disease) target conditions with a control group of nontarget conditions. Each model used 3 time periods: baseline (15 months before program announcement), an intervening period between announcement and implementation, and a 2-year post-implementation period, with specific dates defined by HRRP policies. DATA COLLECTION/EXTRACTION METHODS: We derived a 20% random sample of all hospitalizations for beneficiaries continuously enrolled for 12 months before hospitalization (N = 7,162,189). PRINCIPAL FINDINGS: Observation stays increased similarly for the initial HRRP target and nontarget conditions in the intervening period (0.01% points per month [95% CI -0.01, 0.3]). Post-implementation, observation stays increased significantly more for target versus nontarget conditions, but the difference is quite small (0.02% points per month [95% CI 0.002, 0.04]). Results for the COPD analysis were statistically insignificant in both policy periods. CONCLUSIONS: The increase in observation stays is likely due to other factors, including audit activity and clinical advances.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2023) conducted a cohort in Hospitalizations for HRRP target conditions (acute myocardial infarction, pneumonia, heart failure, and COPD) versus nontarget conditions (n=7,162,189). Medicare's Hospital Readmissions Reduction Program (HRRP) target condition status vs. Nontarget conditions (with observation stays comprising <10% of total hospitalizations in the pre-period) was evaluated on Monthly change in observation stays as a proportion of total hospitalizations in the post-HRRP implementation period (MD 0.02% points per month, 95% CI 0.002, 0.04). Medicare's HRRP was associated with a minimal post-implementation differential increase in observation stays for target versus nontarget conditions of 0.02% points per month.
Synapse has enriched 10 related papers. Consider them for comparative context: